MMP9 and central nervous system cancer: What makes this study interesting is that treatment of miR-211 and shRNA targeting MMP-9 together with temozolomide increased apoptotic DNA fragmentation in glioma CSCs as well as reduced drug efflux by Pgp, which is a well-known mechanism of chemoresistance [128].